# Burden of Cytomegalovirus Reactivation in Pediatric Patients After Allogeneic Hematopoietic Stem Cell Transplantation

> **NCT06916195** · — · RECRUITING · sponsor: **MSD Italia S.r.l.** · enrollment: 230 (estimated)

## Conditions studied

- Cytomegalovirus Infection
- Hematopoietic Stem Cells Transplantation

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06916195
- **Lead sponsor:** MSD Italia S.r.l.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-09
- **Primary completion:** 2026-04-30
- **Final completion:** 2026-07-15
- **Target enrollment:** 230 (ESTIMATED)
- **Last updated:** 2026-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06916195

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06916195, "Burden of Cytomegalovirus Reactivation in Pediatric Patients After Allogeneic Hematopoietic Stem Cell Transplantation". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06916195. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*